Deegtal
Geneva
About Deegtal
dEEGtal’s use of AI to expedite epilepsy diagnosis could make a significant difference in patient care, by analyzing EEG data quickly, it might help identify patterns or anomalies that could be missed by human reviewers alone.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.9M
- Funding stage: Seed
- Last round: Grant (Sep 2025)
- Website: deegtal.ai
Industries & Categories
Artificial Intelligence (AI), Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/deegtal-115614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.